Xiang Wang

Xiang Wang

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2020 in ACS Nano
Verified
Journal Article
Closed access
Kuo-Ching MeiKuo-Ching Mei
Kuo-Ching Mei
YLYu-Pei Liao
Yu-Pei Liao
JJJinhong Jiang
Jinhong Jiang
MCMichelle Chiang
Michelle Chiang
MKMercedeh Khazaieli
Mercedeh Khazaieli
ANAndre Nel
Andre Nel


28 February 2023 in ACS Nano
Verified
Journal Article
Open access
XXXiao Xu
Xiao Xu
Xiang WangXiang Wang
Xiang Wang
YLYu-Pei Liao
Yu-Pei Liao
LLLijia Luo
Lijia Luo
Tian XiaTian Xia
Tian Xia
ANAndre Nel
Andre Nel
While oral desensitization is capable of alleviating peanut allergen anaphylaxis, long-term immune tolerance is the sought-after goal. We developed a liver-targeting lipid nanoparticle (LNP) platform to deliver mRNA-encoded peanut allergen epitopes to liver sinusoidal endothelial cells (LSECs), which function as robust tolerogenic antigen-presenting cells that induce FoxP3+ regulatory T-cells (Tregs). The mRNA strand was constructed by including nucleotide sequences encoding for nonallergenic MHC-II binding T-cell epitopes, identified in the dominant peanut allergen, Ara h2. These epitopes were inserted in the mRNA strand downstream of an MHC-II targeting sequence, further endowed in vitro with 5' and 3' capping sequences, a PolyA tail, and uridine substitution. Codon-optimized mRNA was used for microfluidics synthesis of LNPs with an ionizable cationic lipid, also decorated with a lipid-anchored mannose ligand for LSEC targeting. Biodistribution to the liver was confirmed by in vivo imaging, while ELISpot assays demonstrated an increase in IL-10-producing Tregs in the spleen. Prophylactic administration of tandem-repeat or a combination of encapsulated Ara h2 epitopes induced robust tolerogenic effects in C3H/HeJ mice, sensitized to and subsequently challenged with crude peanut allergen extract. In addition to alleviating physical manifestations of anaphylaxis, there was suppression of Th2-mediated cytokine production, IgE synthesis, and mast cell release, accompanied by increased IL-10 and TGF-β production in the peritoneum. Similar efficacy was demonstrated during LNP administration postsensitization. While nondecorated particles had lesser but significant effects, PolyA/LNP-Man lacked protective effects. These results demonstrate an exciting application of mRNA/LNP for treatment of food allergen anaphylaxis, with the promise to be widely applicable to the allergy field.

1 April 2021 in Nano Today
Verified
Journal Article
Closed access
JLJiulong Li
Jiulong Li
Xiang WangXiang Wang
Xiang Wang
Kuo-Ching MeiKuo-Ching Mei
Kuo-Ching Mei
CCChong Hyun Chang
Chong Hyun Chang
JJJinhong Jiang
Jinhong Jiang
Tian XiaTian Xia
Tian Xia

28 August 2019 in Small
Verified
Journal Article
Closed access
PDF file
Xiang WangXiang Wang
Xiang Wang
CCChong Hyun Chang
Chong Hyun Chang
JJJinhong Jiang
Jinhong Jiang
QLQi Liu
Qi Liu
YLYu‐Pei Liao
Yu‐Pei Liao
Tian XiaTian Xia
Tian Xia

22 December 2020 in ACS Nano
Verified
Journal Article
Closed access
QI LIUQI LIU
QI LIU
Xiang WangXiang Wang
Xiang Wang
Xiangsheng LiuXiangsheng Liu
Xiangsheng Liu
YLYu-Pei Liao
Yu-Pei Liao
CCChong Hyun Chang
Chong Hyun Chang
ANAndre Nel
Andre Nel